Citizens Business Bank’s Edwards Lifesciences EW Stock Holding History

Citizens Business Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Sell	29,865 -1,104	-4%	-$92.5K	0.41%	61
2026 Q1	$2.48M	Sell	30,969 -55	-0.2%	-$4.53K	0.41%	62
2025 Q4	$2.64M	Buy	31,024 +548	+2%	+$45K	0.44%	58
2025 Q3	$2.37M	Buy	30,476 +518	+2%	+$40.5K	0.4%	58
2025 Q2	$2.34M	Buy	29,958 +1,354	+5%	+$101K	0.46%	60
2025 Q1	$2.07M	Buy	28,604 +5,454	+24%	+$390K	0.45%	60
2024 Q4	$1.9M	Sell	23,150 -10,039	-30%	-$703K	0.36%	61
2024 Q3	$2.19M	Sell	33,189 -885	-3%	-$64.3K	0.44%	63
2024 Q2	$3.15M	Sell	34,074 -201	-0.6%	-$17.8K	0.67%	49
2024 Q1	$3.28M	Buy	+34,275	New	+$2.88M	0.68%	47

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Citizens Business Bank's EW Position: Q2 2026 in Review

Citizens Business Bank reduced its Edwards Lifesciences (EW) stake by 3.6% in Q2 2026, selling an estimated $92.5K and leaving 29,865 shares worth $2.7M. The position accounts for 0.41% of the portfolio, ranked #61.

Citizens Business Bank first reported a position in EW in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.28M in Q1 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Citizens Business Bank held 29,865 shares of Edwards Lifesciences worth $2.7M as of Q2 2026.
Citizens Business Bank sold 1,104 Edwards Lifesciences shares in Q2 2026, an estimated $92.5K.
Edwards Lifesciences made up 0.41% of Citizens Business Bank's portfolio in Q2 2026, its #61 holding.
Citizens Business Bank first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
Citizens Business Bank's Edwards Lifesciences position peaked at $3.28M in Q1 2024.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Citizens Business Bank's 13F filing for Q2 2026, filed 3 Aug 2026.